Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Naito

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Advances in Experimental Medicine and Biology|September 3, 2017
Drebrin and Spine FormationHideto Takahashi, Yusuke Naito
Expert Opinion on Pharmacotherapy|March 26, 2026
Persistence of fixed-dose combinations including dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes in Japan: analysis using a claims databaseKohei Kaku, Yusuke Naito
Pediatrics International : Official Journal of the Japan Pediatric Society|May 21, 2014
Insulin glargine in pediatric patients with type 1 diabetes in JapanTatsuhiko Urakami, Yusuke Naito, Yutaka Seino
Diabetes & Metabolic Syndrome|September 6, 2015
Evaluation of unmet medical need among Japanese patients with type 2 diabetes mellitus and efficacy of Lixisenatide treatment among Asian type 2 diabetes mellitus patientsYasuo Terauchi, Yusuke Naito, Yukio Ikeda
Expert Opinion on Drug Safety|June 13, 2025
Safety and effectiveness of empagliflozin in Japanese patients with heart failure: a 1-year post-marketing surveillance study stratified by ageKazuhiro Yamamoto, Yusuke Naito, Sakurako Watanabe
Journal of Diabetes and Its Complications|December 3, 2014
Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) studyMasato Odawara, Takashi Kadowaki, Yusuke Naito
Diabetology & Metabolic Syndrome|November 24, 2015
Evaluation of the efficacy and safety of lixisenatide add-on treatment to basal insulin therapy among T2DM patients with different body mass indices from GetGoal trialsKazuhiro Eto, Yusuke Naito, Yutaka Seino
Journal of Anesthesia|March 5, 2017
The role of Perioperative Surgical Home on health and longevity in society: importance of the surgical prehabilitation programMasahiko Kawaguchi, Mitsuru Ida, Yusuke Naito
Diabetology & Metabolic Syndrome|February 18, 2014
Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysisMasato Odawara, Takashi Kadowaki, Yusuke Naito
Neuroscience Research|October 5, 2016
Emerging roles of the neurotrophin receptor TrkC in synapse organizationYusuke Naito, Alfred Kihoon Lee, Hideto Takahashi
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Advances in Experimental Medicine and Biology|September 3, 2017
Drebrin and Spine FormationHideto Takahashi, Yusuke Naito
Expert Opinion on Pharmacotherapy|March 26, 2026
Persistence of fixed-dose combinations including dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes in Japan: analysis using a claims databaseKohei Kaku, Yusuke Naito
Pediatrics International : Official Journal of the Japan Pediatric Society|May 21, 2014
Insulin glargine in pediatric patients with type 1 diabetes in JapanTatsuhiko Urakami, Yusuke Naito, Yutaka Seino
Diabetes & Metabolic Syndrome|September 6, 2015
Evaluation of unmet medical need among Japanese patients with type 2 diabetes mellitus and efficacy of Lixisenatide treatment among Asian type 2 diabetes mellitus patientsYasuo Terauchi, Yusuke Naito, Yukio Ikeda
Expert Opinion on Drug Safety|June 13, 2025
Safety and effectiveness of empagliflozin in Japanese patients with heart failure: a 1-year post-marketing surveillance study stratified by ageKazuhiro Yamamoto, Yusuke Naito, Sakurako Watanabe
Journal of Diabetes and Its Complications|December 3, 2014
Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) studyMasato Odawara, Takashi Kadowaki, Yusuke Naito
Diabetology & Metabolic Syndrome|November 24, 2015
Evaluation of the efficacy and safety of lixisenatide add-on treatment to basal insulin therapy among T2DM patients with different body mass indices from GetGoal trialsKazuhiro Eto, Yusuke Naito, Yutaka Seino
Journal of Anesthesia|March 5, 2017
The role of Perioperative Surgical Home on health and longevity in society: importance of the surgical prehabilitation programMasahiko Kawaguchi, Mitsuru Ida, Yusuke Naito
Diabetology & Metabolic Syndrome|February 18, 2014
Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysisMasato Odawara, Takashi Kadowaki, Yusuke Naito
Neuroscience Research|October 5, 2016
Emerging roles of the neurotrophin receptor TrkC in synapse organizationYusuke Naito, Alfred Kihoon Lee, Hideto Takahashi
Pageof 9